Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Published July 10, 2024
Retatrutide represents a novel generation of research compounds in the anti-obesity and antidiabetic field, characterized by its unique mechanism of action involving the simultaneous activation of three metabolically relevant receptors: the GCG-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the GCG receptor (GCGR)
Important evidence boundary No formal human clinical trial has ever evaluated IGF-1 LR3 for any therapeutic or performance endpoint
Campos, Julia (2025) GLP-1RAs Show Therapeutic Potential in Mast Cell-Driven Diseases
US$ 20.39
US$ 23.76
US$ 24.98
US$ 29.13
US$ 20.24
US$ 24.10
US$ 24.97
